| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/29/2005 | US20050215633 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means |
| 09/29/2005 | US20050215616 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol; treating vaginal and skin atrophy |
| 09/29/2005 | US20050215613 with indazole or thienopyrazole compounds such as 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl-indazole |
| 09/29/2005 | US20050215593 Kaposi's sarcoma; Crohn's disease |
| 09/29/2005 | US20050215559 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders |
| 09/29/2005 | US20050215557 For therapy and prophylaxis of inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis or rheumatoid arthritis etc |
| 09/29/2005 | US20050215553 For therapy and prophylaxis of cardiovascular, central nervous system, inflammatory, and bone diseases as well as infectious diseases and certain cancers |
| 09/29/2005 | US20050215550 Pyrazole-derived kinase inhibitors and uses thereof |
| 09/29/2005 | US20050215549 TACE inhibitors |
| 09/29/2005 | US20050215547 Optically active pyridine derivative and a medicament containing the same |
| 09/29/2005 | US20050215528 Gnrh agonist combination drugs |
| 09/29/2005 | US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/29/2005 | US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens |
| 09/29/2005 | US20050215497 Treating prostate cancer by administering double stranded oligonucleotide having two complementary oligonucleotide sequences forming a hybrid; each sequence has at one 3' or 5' end 1-5 unpaired nucleotides forming single-strand ends extending beyond the hybrid |
| 09/29/2005 | US20050215493 Calcium-containing tissue strengthening agents and use thereof |
| 09/29/2005 | US20050215480 Alpha conotoxin peptides with analgesic properties |
| 09/29/2005 | US20050214910 Chordin-like molecules and uses thereof |
| 09/29/2005 | US20050214856 Nucleotide sequences coding bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 09/29/2005 | US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins |
| 09/29/2005 | US20050214392 Treatments for immune systems disorders |
| 09/29/2005 | US20050214391 Method and composition for the treatment of dermatologic diseases |
| 09/29/2005 | US20050214334 Composition for topical substance delivery |
| 09/29/2005 | US20050214295 Combined chemotherapy compositions and methods for the treatment of cancer, ischemia-reperfusion injury, and septic shock |
| 09/29/2005 | US20050214291 Treatment method |
| 09/29/2005 | US20050214272 Antiinflammatory agents for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 09/29/2005 | US20050214252 Chordin-like molecules and uses thereof |
| 09/29/2005 | US20050214247 Glycodendrimers having biological activity |
| 09/29/2005 | DE10393402T5 Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen Means and Toilettenartikel- or pharmaceutical composition to accelerate the uptake of basic amino acids in cells |
| 09/29/2005 | CA2562388A1 Emulsion-stabilized preparation |
| 09/29/2005 | CA2560953A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient |
| 09/29/2005 | CA2559838A1 Y2 selective receptor agonists for therapeutic interventions |
| 09/29/2005 | CA2559545A1 Tetra-cyclic carboline derivatives for inhibiting angiogenesis |
| 09/29/2005 | CA2559196A1 Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents |
| 09/29/2005 | CA2558126A1 The treatment of inflammatory disorders and pain using beta-aminoalcohols |
| 09/29/2005 | CA2558096A1 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition |
| 09/28/2005 | EP1580192A2 16-Hydroxyestratrienes as selective estrogens |
| 09/28/2005 | EP1580188A1 Aryl ureas as kinase inhibitors |
| 09/28/2005 | EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof |
| 09/28/2005 | EP1578988A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 09/28/2005 | EP1578981A2 Tumor endothelial marker 7alpha molecules and uses thereof |
| 09/28/2005 | EP1578799A2 Antibodies directed to tumor necrosis factor and uses thereof |
| 09/28/2005 | EP1578771A2 Remodeling and glycoconjugation of peptides |
| 09/28/2005 | EP1578750A2 Cationic porphyrin derivatives as antibacterial agents |
| 09/28/2005 | EP1578429A2 Protease inhibitors |
| 09/28/2005 | EP1578348A2 Formulation comprising bioactive agents and method of using same |
| 09/28/2005 | EP1463731B1 Dibenzodiazepine derivates, their preparation and use |
| 09/28/2005 | EP1448521B1 Derivatives of andrimide and moiramide b having antibacterial properties |
| 09/28/2005 | EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 09/28/2005 | EP1366029B1 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolins and the utilization thereof as anticoagulant and antithrombotic agents |
| 09/28/2005 | EP1361880B1 6-substituted pyrido-pyrimidines |
| 09/28/2005 | EP1299365B1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 09/28/2005 | EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 09/28/2005 | EP1296722B1 Radiotherapy |
| 09/28/2005 | EP1255546B9 Method for improving bone modeling and chondrocyte functioning in growing canines |
| 09/28/2005 | EP1243583B1 Heterocyclic compounds having sulfonamide groups |
| 09/28/2005 | EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 09/28/2005 | EP1210348B1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 09/28/2005 | EP1135486B1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 09/28/2005 | EP1117422B1 Use of op-1 for the preparation of a pharmaceutical composition for repairing a defect locus in a non articular cartilage tissue of a mammal |
| 09/28/2005 | EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid |
| 09/28/2005 | CN1675357A Pramyxovirus vectors encoding antibody and utilization thereof |
| 09/28/2005 | CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation |
| 09/28/2005 | CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 09/28/2005 | CN1675218A Novel tricyclic spiropiperidines or spiropyrrolidines |
| 09/28/2005 | CN1675208A Novel fused imidazole derivative |
| 09/28/2005 | CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 09/28/2005 | CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 09/28/2005 | CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/28/2005 | CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1675184A Caspase inhibitors and uses thereof |
| 09/28/2005 | CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 09/28/2005 | CN1674931A T cell receptor CDR3 sequences and methods for detection |
| 09/28/2005 | CN1674927A Growth hormone releasing peptides |
| 09/28/2005 | CN1674924A Use of fermented wheat germ extract as anti-inflammatory agent |
| 09/28/2005 | CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis |
| 09/28/2005 | CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 09/28/2005 | CN1674920A Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 09/28/2005 | CN1674914A Female hormone-containing patch |
| 09/28/2005 | CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 09/28/2005 | CN1220451C 健康食品 Healthy Food |
| 09/27/2005 | US6949655 Acyclic piperidine derivatives |
| 09/27/2005 | US6949648 Condensed pyrazole derivatives, process for producing the same and use thereof |
| 09/27/2005 | US6949643 Thiazolopytimidines and their use as modulators of chemokine receptor activity |
| 09/27/2005 | US6949585 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 09/27/2005 | US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders |
| 09/27/2005 | US6949578 useful in selectively inhibiting or antagonizing the alpha v beta 3 and/or alpha v beta 5 integrins; treatment of osteoporosis, humoral hypercalcemia of malignancy, Paget's disease, tumor metastasis, solid tumor growth (neoplasia), angiogenesis |
| 09/27/2005 | US6949575 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives |
| 09/27/2005 | US6949566 For use as metalloproteinase inhibitors |
| 09/27/2005 | US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 09/27/2005 | US6949545 Tissue remodeling; antiinflammatory agents; autoimmune disease |
| 09/27/2005 | US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 09/27/2005 | US6949540 Substituted pyrazoles |
| 09/27/2005 | US6949539 Antiinflammatory agents; autoimmune disease; rheumatic disorders |
| 09/27/2005 | US6949535 for example, 2-(6-aminopurin-9-ylmethyl)-3-(2-chlorophenyl)-6,7-dimethoxy-3H-quinazolin-4-one |
| 09/27/2005 | US6949525 In particular the treatment of osteochondral lesions associated with osteoarthritis by means of intraarticular application of a mixture of hyaluronate and chondroitin sulfate |
| 09/27/2005 | US6949515 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases |
| 09/27/2005 | US6949510 Uses of diterpenoid triepoxides as an anti-proliferative agent |